Vitek; Michael P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vitek; Michael P..The latest application filed is for "apoe peptide dimers and uses thereof".

Company Profile

0.17.14

Vitek; Michael P. - Research Triangle Park NC
Vitek; Michael P. - Cary NC
VITEK; Michael P. - Rescarch Triangle NC
Vitek; Michael P. - Apex NC
Vitek; Michael P. - East Norwich NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
ApoE peptide dimers and uses thereof Grant 9,815,884 - Vitek , et al. November 14, 2	2017-11-14
ApoE peptide dimers and uses thereof Grant 9,809,640 - Vitek , et al. November 7, 2	2017-11-07
Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide Grant 9,730,979 - Vitek , et al. August 15, 2	2017-08-15
Apoe Peptide Dimers And Uses Thereof App 20160096877 - VITEK; Michael P. ; et al.	2016-04-07
Apoe Peptide Dimers And Uses Thereof App 20160008424 - VITEK; Michael P. ; et al.	2016-01-14
Methods of inhibiting calcineurin with ApoE analogs Grant 8,629,242 - Vitek , et al. January 14, 2	2014-01-14
Methods of diagnosing cancer Grant 8,623,601 - Vitek , et al. January 7, 2	2014-01-07
Methods Of Diagnosing Cancer App 20130018001 - Vitek; Michael P. ; et al.	2013-01-17
Apoe Peptide Dimers And Uses Thereof App 20130005645 - VITEK; Michael P. ; et al.	2013-01-03
Treatment of subarachnoid hemorrhage with ApoE analogs Grant 8,288,336 - Vitek , et al. October 16, 2	2012-10-16
ApoE analogs and methods for their use Grant 8,288,335 - Vitek , et al. October 16, 2	2012-10-16
Treatment Of Subarachnoid Hemorrhage With Apo E Analogs App 20120053120 - VITEK; Michael P. ; et al.	2012-03-01
Apoe Analogs And Methods For Their Use App 20110306550 - VITEK; Michael P. ; et al.	2011-12-15
Treatment of subarachnoid hemorrhage with Apo E analogs Grant 8,034,762 - Vitek , et al. October 11, 2	2011-10-11
Methods Of Treating Cancer With Apoe Peptides App 20110166079 - Vitek; Michael P. ; et al.	2011-07-07
APO E analogs and methods for their use Grant 7,947,645 - Vitek , et al. May 24, 2	2011-05-24
Methods Of Inhibiting Calcineurin With Apoe Analogs App 20100305024 - Vitek; Michael P. ; et al.	2010-12-02
Methods For Modulating Set And Uses Thereof App 20100144627 - Vitek; Michael P. ; et al.	2010-06-10
Treatment of Subarachnoid Hemorrhage With APO E Analogs App 20090131315 - VITEK; MICHAEL P. ; et al.	2009-05-21
Apo E Analogs And Methods For Their Use App 20090042783 - Vitek; Michael P. ; et al.	2009-02-12
Assays for measuring matrix metalloproteinase activities Grant 7,432,061 - Moss , et al. October 7, 2	2008-10-07
Treatment for neurodegenerative diseases App 20060281817 - Colton; Carol A. ; et al.	2006-12-14
Assays for measuring matrix metalloproteinase activities App 20030229005 - Moss, Marcia Lynn ; et al.	2003-12-11
Transgenic mouse expressing human tau gene Grant 6,593,512 - Vitek , et al. July 15, 2	2003-07-15
Modulation of nitric oxide production Grant 6,436,996 - Vitek , et al. August 20, 2	2002-08-20
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis Grant 6,410,598 - Vitek , et al. June 25, 2	2002-06-25
Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts Grant 5,935,927 - Vitek , et al. August 10, 1	1999-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.